AstraZeneca PLC Stock: price and insider trades · Sweden

AstraZeneca PLC, classified in the Health Care sector, is a listed company based in Cambridge, Sweden, founded in 1913. Its insiders report their share dealings to Finansinspektionen. 15 insiders have disclosed 33 filings since 18 October 2025.

Both sides are active: 12 purchases worth €16.4M and 5 sales worth €3.3M, from 7 insiders and 5 insiders respectively. No amount is published for 7 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The largest single trade was a purchase of €8.5M by Pascal Soriot, published on 18 September 2026, equal to 0.0037% of the market capitalisation. The buyers include 2 board members, 2 finance chiefs and 2 chief executives.

Compared with its exchange (886 companies, median 7 filings), a count of 33 filings is above the norm. Over the whole record (from 2023), the tally stands at 32 purchases and 7 sales.

In all, 2 purchases were made within 30 days of a purchase by another insider of the company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The last insider purchase was made public on 18 September 2026, 29 days ago. Filings reach the Finansinspektionen feed a median of 2 days after the trade. The legal deadline for notifying a trade is three business days (MAR article 19).

Other companies in the same sector with recent insider buying flagged by our signals: MAIA Biotechnology, Inc. and Cooper Companies, Inc. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.